BioRAE

BioRAE is a private drug-delivery biotechnology company associated with biomaterials researcher Ali Khademhosseini and built around a gelatin methacryloyl microneedle platform developed at UCLA. The company appears to focus on biocompatible, biodegradable microneedle delivery systems intended to enable transdermal administration of a range of therapeutic compounds. Publicly available information on BioRAE is sparse, and the company does not appear to maintain a robust standalone public operating profile, but it is documented as the licensor of GelMA-MN technology to PharmaTher for psychedelic pharmaceutical applications. Based on the available evidence, BioRAE is best characterized as an early-stage platform company centered on biomaterials-enabled drug delivery rather than a fully disclosed therapeutic pipeline company.